Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.87 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.87 |
| ▸ | NPC1 | O15118 | 2/20 | 0.87 |
| ▸ | RAB9A | P51151 | 2/20 | 0.87 |
| ▸ | MEN1 | O00255 | 2/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.87 |
| ▸ | MAPT | P10636 | 2/20 | 0.87 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.87 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.87 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.87 |
| ▸ | PRKCA | P17252 | 2/20 | 0.54 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13135364 | 0.93 | LMNA (0.77) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL13370284 | 0.93 | MEN1 (1.00) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL5553577 | 0.90 | MAPT (0.72) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL8030800 | 0.89 | LMNA (0.70) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL13909079 | 0.88 | MAPT (0.69) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL14100826 | 0.88 | LMNA (0.69) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL13135365 | 0.85 | NPC1 (0.65) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL6067543 | 0.84 | MAPT (0.64) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL11601873 | 0.84 | MAPT (0.64) | LMNAMAPK1NPC1RAB9AMEN1 | |
| SCHEMBL10732288 | 0.82 | NPC1 (0.62) | LMNAMAPK1NPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116574020-A | Preparation and application of long-term stable silicone hydrogel contact lens colorant | 华诺森(湖北)光学有限公司 | 2023-08-11 | — | — | CN | claimed |
| US-7504495-B2 | Quencher compositions comprising anthraquinone moieties | EXIQON A/S (DK) | 2009-03-17 | — | — | US | claimed |
| EP-1538154-B1 | Quencher composition comprising anthraquinone moieties | EXIQON AS (DK) | 2008-12-31 | — | — | EP | claimed |
| EP-1831394-A2 | PROBES, LIBRARIES AND KITS FOR ANALYSIS OF MIXTURES OF NUCLEIC ACIDS AND METHODS FOR CONSTRUCTING THE SAME | Exiqon A/S (DK) | 2007-09-12 | — | — | EP | claimed |
| US-20060166238-A1 | Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same | EXIQON A/S (DK) | 2006-07-27 | — | — | US | claimed |
| WO-2006066592-A2 | PROBES, LIBRARIES AND KITS FOR ANALYSIS OF MIXTURES OF NUCLEIC ACIDS AND METHODS FOR CONSTRUCTING THE SAME | EXIQON A/S (DK) | 2006-06-29 | — | — | WO | claimed |
| US-20050227254-A1 | Quencher compositions comprising anthraquinone moieties | QIAGEN GMBH (DE) | 2005-10-13 | — | — | US | claimed |
| EP-1538154-A1 | Quencher composition comprising anthraquinone moieties | Exiqon A/S (DK) | 2005-06-08 | — | — | EP | claimed |
| WO-2024074814-A9 | COMPOSITION COMPRISING A FUNCTIONALISED DYE AND A DIALLYLAMINE COMONOMER AND USE THEREOF | SUBLINO LIMITED (GB) | 2025-05-22 | — | — | WO | disclosed |
| US-20240209420-A1 | COMPOSITIONS AND METHODS FOR MULTIPLEX DETECTION OF MIRNA AND OTHER POLYNUCELOTIDES | KASA BIO, L.L.C. | 2024-06-27 | — | — | US | disclosed |
| EP-4388133-A2 | COMPOSITIONS AND METHODS FOR MULTIPLEX DETECTION OF MIRNA AND OTHER POLYNUCELOTIDES | Kasa Bio, L.L.C. (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11952617-B2 | Methods for multiplex detection of polynucleotides using unbound fluorescent probes and quencher oligonucleotides | KASA BIO, L.L.C. (US) | 2024-04-09 | — | — | US | disclosed |
| US-20230265490-A1 | COMPOSITIONS AND METHODS FOR MULTIPLEX DETECTION OF MIRNA AND OTHER POLYNUCLEOTIDES | KASA BIO, L.L.C. | 2023-08-24 | — | — | US | disclosed |
| CN-116574020-A | Preparation and application of long-term stable silicone hydrogel contact lens colorant | 华诺森(湖北)光学有限公司 | 2023-08-11 | — | — | CN | disclosed |
| WO-2005098029-A2 | METHODS FOR QUANTIFICATION OF MICRORNAS AND SMALL INTERFERING RNAS | EXIQON A/S (DK) | 2005-10-20 | — | — | WO | disclosed |
| US-20050227254-A1 | Quencher compositions comprising anthraquinone moieties | QIAGEN GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-1538154-A1 | Quencher composition comprising anthraquinone moieties | Exiqon A/S (DK) | 2005-06-08 | — | — | EP | disclosed |
| EP-0555361-B1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | EASTMAN CHEM CO (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0555361-A1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF. | EASTMAN KODAK CO (US) | 1993-08-18 | — | — | EP | disclosed |
| WO-1992007913-A1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | EASTMAN KODAK COMPANY (US) | 1992-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227254-A1 | Quencher compositions comprising anthraquinone moieties | ANXA5, SUN2, ANXA3 | LMNA 522/4885MAPK1 2569/4885NPC1 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.